Scarinci Hollenbeck regularly publishes articles pertaining to legal updates affecting individuals and institutions in New York and New Jersey, and the world at large. Here you can find coverage for when we welcome new attorneys, significant wins we’ve secured on behalf of our clients, and general announcements.
Results for fda articles
Key Takeaways from the FDA’s Review of CBD Products for Mislabeling and Adulteration
Author: Daniel T. McKillopDate: July 27, 2020
The U.S. Food and Drug Administration (FDA) recently sent an overdue report to Congress regarding its review of cannabidiol (CBD) products for mislabeling and adulteration. The FDA report revealed that mislabeling and adulteration are not widespread, it did find that the actual CBD content in many products did not match the content described in these products’ labeling.
According to the FDA, its findings support the need for additional studies. “FDA believes that understanding the characteristics of marketed CBD products is critical to making informed decisions about how best to protect public health in the current marketplace,” the report states.
FDA Seeking to Define “Natural” for Food Labeling
As store shelves become crowded with products that feature food labeling purporting to be “natural,” the U.S. Food and Drug...
Will DEA Proposal Put Psychedelics on the Map?
The DEA is proposing a massive increase in the production quotas of cannabis, psilocin, and psilocybin (“magic mushrooms”) for research...
COVID-19 Update: What School Districts Need to Know About Vaccination, Testing, & Quarantine
Governor Murphy issued Executive Order 253, which requires all covered workers of school districts to either provide adequate proof that...
Sponsors of Federal Cannabis Legalization Bill Flooded With Feedback
While most are applauding Senate Majority Leader Chuck Schumer (D-NY) for his work to legalize cannabis on the federal level,...
Court Dismisses Lawsuit Over “Slightly Sweet” Tea
September 15, 2021
Coca-Cola Co. did not mislead consumers by labeling its Gold Peak iced tea as “slightly sweet,” according to a federal...
Breaking Down the New Federal Cannabis Legalization Bill
August 27, 2021
Senate Democrats introduced draft legislation that would end the federal prohibition of cannabis and remove cannabis from the Controlled Substances...
Divided Supreme Court Narrows Doctrine of Patent Assignor Estoppel
July 29, 2021
In Minerva Surgical Inc. v. Hologic Inc., the U.S. Supreme Court declined to abolish the doctrine of patent assignor estoppel......
Can NJ Employers Mandate COVID-19 Vaccinations for Employees to Return to Work?
June 24, 2021
While return to work plans involve a number of important considerations, one of the most significant (and controversial) is whether...
Baby Food Companies Face Class Action Suits Regarding Toxic Chemicals
May 28, 2021
In the wake of a congressional report revealing high levels of heavy toxic metal contamination in several brands of popular...
- Client Alert|49
- COVID-19 Alerts|66
- COVID-19 Education Alerts|22
- Cyber Security Client Alert|5
- Firm Events|111
- Firm Insights|2654
- Firm News|408
- Just In|319
- Quick News|62
- Business Law|612
- Entertainment and Sports|429
- Labor and Employment|316
- Intellectual Property|164
- Cyber Security|156
- Cannabis Law|120
- Commercial Real Estate|44